Reports
Showing 217–228 of 294 results
-
Select options This product has multiple variants. The options may be chosen on the product page
Biosimilar Primer: US Physicians’ Attitudes, Beliefs, and Intentions
$850.00 – $1,700.00 -
Select options This product has multiple variants. The options may be chosen on the product page
CRO Quality Benchmarking—Phase I Service Providers (6th Edition)
$4,900.00 – $9,800.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Lung Cancer: Clinical Trial Overview
$960.00 – $1,920.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Bladder Cancer: Disease and Pipeline Analysis
$2,960.00 – $5,920.00 -
Select options This product has multiple variants. The options may be chosen on the product page
2014 Service Provider Message Targeting and Segmentation Tool
$960.00 – $1,920.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Gilead Sciences Clinical Development Profile
$700.00 – $1,400.00 -
Select options This product has multiple variants. The options may be chosen on the product page
CRO Quality Benchmarking – Phase II/III Service Providers (6th edition)
$6,800.00 – $13,600.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices
$750.00 – $1,500.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Contract Manufacturer Quality Benchmarking (2014)
$4,900.00 – $9,800.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Headaches: Current Treatments, Unmet Needs, and Patient Recruitment
$2,960.00 – $5,920.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Forest Labs Clinical Development Profile
$700.00 – $1,400.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis
$2,960.00 – $5,920.00